Larry Goldstein to Cholesterol, HDL
This is a "connection" page, showing publications Larry Goldstein has written about Cholesterol, HDL.
Connection Strength
0.193
-
Baseline blood pressure, low- and high-density lipoproteins, and triglycerides and the risk of vascular events in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Atherosclerosis. 2009 Jun; 204(2):515-20.
Score: 0.075
-
Statins for stroke prevention. Curr Atheroscler Rep. 2007 Oct; 9(4):305-11.
Score: 0.071
-
Atherogenic dyslipidemia and residual cardiovascular risk in statin-treated patients. Stroke. 2014 May; 45(5):1429-36.
Score: 0.028
-
Relative and cumulative effects of lipid and blood pressure control in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels trial. Stroke. 2009 Jul; 40(7):2486-92.
Score: 0.020